| 送交者: qa[★品衔R6★] 于 2020-11-15 5:27 已读 920 次 | qa的个人频道 |
Fifth China Covid Vaccine Enters Phase 3 Trial, Xinhua SaysBloomberg News
14 November 2020, 10:39 pm AEDT 6park.com 6park.com 6park.com6park.com 6park.com
Covid Vaccine Puts Shipping Companies in Position to Save the World
6park.comSHARE THIS ARTICLE
6park.comShare 6park.com 6park.comTweet 6park.com 6park.comPost 6park.com 6park.comEmail 6park.com[iframe][/iframe] 6park.comIn this article
6park.com
3904771Z 6park.comXINHUA NEWS AGENCY 6park.comPrivate Company
6park.com
300122 6park.comCHONGQING ZHIF-A 6park.com131.94 6park.comCNY 6park.com-3.06-2.27%
6park.com
SVA 6park.comSINOVAC BIOTECH 6park.comUSD 6park.com+null+null%
6park.comSign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis. 6park.com
China’s fifth Covid-19 vaccine candidate has entered a phase 3 trial, state media Xinhua News Agency reported. 6park.com
The vaccine, developed by China’s Anhui Zhifei Longcom Biopharmaceutical, will be tested on 5,000 volunteers in Uzbekistan, the report said, citing the Uzbek government. They are between the ages of 18 and 59, and will join the late-stage human trials that are expected to last for a year, Xinhua said. 6park.com
[iframe][/iframe] 6park.comThe Anhui-based pharma firm, a subsidiary of listed Chongqing Zhifei Biological Products, received approval from the local authorities last month to produce a coronavirus vaccine. The trial vaccine has been delivered to Uzbekistan, with Chinese experts monitoring the participants and training Uzbek doctors, Xinhua reported. 6park.com
Chinese vaccine developers have been forced to find countries where the virus is still rampant to host their final-stage trials because its own outbreak has been largely under control. Geopolitical tensions have led to a politicization of the vaccine race with Beijing striving to advance despite criticism over the pandemic’s origins.
Concerns still loom among international vaccine makers as some encounter issues during late-stage trials. The phase 3 trial of China’s Sinovac Biotech Ltd. was halted in Brazil due to a serious adverse event, following similar suspensions among some of their U.S. and U.K. competitors. 6park.com
请点这里投票，“赞”助支持！